Login / Signup

Response to the letter to the editor on "Clinical efficacy and safety of molnupiravir for nonhospitalized and hospitalized patients with COVID-19: A systematic review and meta-analysis of randomized control trials".

Po-Yu HuangTing-Hui LiuJheng-Yan WuYa-Wen TsaiChih-Cheng Lai
Published in: Journal of medical virology (2023)
Keyphrases
  • double blind
  • open label
  • placebo controlled
  • phase iii
  • clinical trial